GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » ROC (Joel Greenblatt) %

Morepen Laboratories (NSE:MOREPENLAB) ROC (Joel Greenblatt) % : 29.59% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Morepen Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 29.59%.

The historical rank and industry rank for Morepen Laboratories's ROC (Joel Greenblatt) % or its related term are showing as below:

NSE:MOREPENLAB' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.31   Med: 16.66   Max: 54.13
Current: 17.9

During the past 13 years, Morepen Laboratories's highest ROC (Joel Greenblatt) % was 54.13%. The lowest was 2.31%. And the median was 16.66%.

NSE:MOREPENLAB's ROC (Joel Greenblatt) % is ranked better than
65.44% of 1062 companies
in the Drug Manufacturers industry
Industry Median: 7.875 vs NSE:MOREPENLAB: 17.90

Morepen Laboratories's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.70% per year.


Morepen Laboratories ROC (Joel Greenblatt) % Historical Data

The historical data trend for Morepen Laboratories's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories ROC (Joel Greenblatt) % Chart

Morepen Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.26 27.42 54.13 39.34 10.94

Morepen Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.31 7.57 13.44 18.67 29.59

Competitive Comparison of Morepen Laboratories's ROC (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's ROC (Joel Greenblatt) % falls into.



Morepen Laboratories ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2844.737 + 2308.261 + 2356.003) - (2438.662 + 0 + 958.518)
=4111.821

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Morepen Laboratories for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1847.68/( ( (2132.095 + max(4111.821, 0)) + (0 + max(0, 0)) )/ 1 )
=1847.68/( ( 6243.916 + 0 )/ 1 )
=1847.68/6243.916
=29.59 %

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Morepen Laboratories  (NSE:MOREPENLAB) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Morepen Laboratories ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories (NSE:MOREPENLAB) Business Description

Traded in Other Exchanges
Address
2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.

Morepen Laboratories (NSE:MOREPENLAB) Headlines

No Headlines